Elisabeth H. Thijssen

Author

Amsterdam University Medical Centers ORCID

Also Known As

Elisabeth H Thijssen, Elisabeth H. Thijssen, Elisabeth Thijssen

Publications

2.1K

Citations

H-Index

Concepts

All Affiliations

Amsterdam University Medical Centers Amsterdam Neuroscience Vrije Universiteit Amsterdam University of California, San Francisco ADx NeuroSciences

About

Elisabeth H. Thijssen is an author at Amsterdam University Medical Centers specializing in alzheimer's disease, neuroscience, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	1.3K
2	Neurology	3	3	1.3K
3	Neuroscience	3	3	1.3K
4	Pathology	2	2	1.3K
5	Aging	2	2	1.3K

Elisabeth H. Thijssen

Publications

Citations

H-Index

Page 1

	Year	Citations
Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration Elisabeth H. Thijssen, Renaud La Joie, Amy Wolf, Nature Medicine Frontotemporal Lobar DegenerationNeurodegenerative DiseasesAlzheimer's DiseaseAgingDiagnostic Value	2020	767
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study Elisabeth H. Thijssen, Renaud La Joie, Amelia Strom, The Lancet Neurology Frontotemporal Lobar DegenerationNeurodegenerative DiseasesAlzheimer's DiseaseAgingDementia	2021	538
Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology Inge M.W. Verberk, Elisabeth H. Thijssen, Jannet Koelewijn, Alzheimer s Research & Therapy	2020	251
Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis Steffi De Meyer, Jolien Schaeverbeke, Inge M.W. Verberk, Alzheimer s Research & Therapy	2020	94
Differential diagnostic performance of a panel of plasma biomarkers for different types of dementia Elisabeth H. Thijssen, Inge M.W. Verberk, Jana Kindermans, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring	2022	83
Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease Elisabeth H. Thijssen, Inge M.W. Verberk, Jeroen Vanbrabant, Scientific Reports	2021	78
<scp>Open‐Label</scp> Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy Lawren VandeVrede, Marian L. Dale, Scott Fields, Movement Disorders Clinical Practice	2020	53
Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment Nidhi S. Mundada, Julio C. Rojas, Lawren VandeVrede, Alzheimer s Research & Therapy	2023	44
Evaluation of Plasma Phosphorylated Tau217 for Differentiation Between Alzheimer Disease and Frontotemporal Lobar Degeneration Subtypes Among Patients With Corticobasal Syndrome Lawren VandeVrede, Renaud La Joie, Elisabeth H. Thijssen, JAMA Neurology	2023	30
Amyloid, pTau, NfL, and GFAP as biomarkers for Alzheimer’s disease Elisabeth H. Thijssen, Inge M.W. Verberk, Erik Stoops, Alzheimer s & Dementia Ongoing AmyloidNeurochemical BiomarkersAlzheimer ’Alzheimer's DiseaseTau Accumulation	2020	17

Page 1